nodes	percent_of_prediction	percent_of_DWPC	metapath
Capreomycin—Nephrotoxicity—Everolimus—kidney cancer	0.0368	0.0368	CcSEcCtD
Capreomycin—Nephritis—Erlotinib—kidney cancer	0.0331	0.0331	CcSEcCtD
Capreomycin—Renal tubular necrosis—Everolimus—kidney cancer	0.0328	0.0328	CcSEcCtD
Capreomycin—Ototoxicity—Paclitaxel—kidney cancer	0.0328	0.0328	CcSEcCtD
Capreomycin—Hypomagnesaemia—Pazopanib—kidney cancer	0.0234	0.0234	CcSEcCtD
Capreomycin—Foetor hepaticus—Everolimus—kidney cancer	0.0206	0.0206	CcSEcCtD
Capreomycin—Nephropathy toxic—Everolimus—kidney cancer	0.0204	0.0204	CcSEcCtD
Capreomycin—Foetor hepaticus—Erlotinib—kidney cancer	0.0199	0.0199	CcSEcCtD
Capreomycin—Abscess—Temsirolimus—kidney cancer	0.0199	0.0199	CcSEcCtD
Capreomycin—Hypomagnesaemia—Everolimus—kidney cancer	0.0184	0.0184	CcSEcCtD
Capreomycin—Hypocalcaemia—Temsirolimus—kidney cancer	0.0172	0.0172	CcSEcCtD
Capreomycin—Liver disorder—Everolimus—kidney cancer	0.0172	0.0172	CcSEcCtD
Capreomycin—Liver disorder—Erlotinib—kidney cancer	0.0166	0.0166	CcSEcCtD
Capreomycin—Induration—Paclitaxel—kidney cancer	0.0147	0.0147	CcSEcCtD
Capreomycin—Nephropathy toxic—Gemcitabine—kidney cancer	0.0137	0.0137	CcSEcCtD
Capreomycin—Injection site haemorrhage—Doxorubicin—kidney cancer	0.0129	0.0129	CcSEcCtD
Capreomycin—Hypocalcaemia—Everolimus—kidney cancer	0.0128	0.0128	CcSEcCtD
Capreomycin—Leukocytosis—Everolimus—kidney cancer	0.0125	0.0125	CcSEcCtD
Capreomycin—Abscess—Sunitinib—kidney cancer	0.0124	0.0124	CcSEcCtD
Capreomycin—Hypomagnesaemia—Gemcitabine—kidney cancer	0.0124	0.0124	CcSEcCtD
Capreomycin—Hepatocellular injury—Everolimus—kidney cancer	0.0117	0.0117	CcSEcCtD
Capreomycin—Nephropathy toxic—Paclitaxel—kidney cancer	0.0114	0.0114	CcSEcCtD
Capreomycin—Hepatocellular injury—Erlotinib—kidney cancer	0.0113	0.0113	CcSEcCtD
Capreomycin—Hypocalcaemia—Sorafenib—kidney cancer	0.0111	0.0111	CcSEcCtD
Capreomycin—Hypocalcaemia—Sunitinib—kidney cancer	0.0107	0.0107	CcSEcCtD
Capreomycin—Hypokalaemia—Temsirolimus—kidney cancer	0.0104	0.0104	CcSEcCtD
Capreomycin—Hypomagnesaemia—Paclitaxel—kidney cancer	0.0103	0.0103	CcSEcCtD
Capreomycin—Hypocalcaemia—Dactinomycin—kidney cancer	0.0101	0.0101	CcSEcCtD
Capreomycin—Deafness—Vinblastine—kidney cancer	0.00954	0.00954	CcSEcCtD
Capreomycin—Renal impairment—Everolimus—kidney cancer	0.00894	0.00894	CcSEcCtD
Capreomycin—Renal failure—Temsirolimus—kidney cancer	0.00866	0.00866	CcSEcCtD
Capreomycin—Renal impairment—Erlotinib—kidney cancer	0.00862	0.00862	CcSEcCtD
Capreomycin—Hypocalcaemia—Gemcitabine—kidney cancer	0.00858	0.00858	CcSEcCtD
Capreomycin—Hypomagnesaemia—Capecitabine—kidney cancer	0.00849	0.00849	CcSEcCtD
Capreomycin—Hearing impaired—Gemcitabine—kidney cancer	0.00825	0.00825	CcSEcCtD
Capreomycin—Hypokalaemia—Everolimus—kidney cancer	0.00774	0.00774	CcSEcCtD
Capreomycin—Hypokalaemia—Erlotinib—kidney cancer	0.00747	0.00747	CcSEcCtD
Capreomycin—Renal impairment—Sunitinib—kidney cancer	0.00746	0.00746	CcSEcCtD
Capreomycin—Hypocalcaemia—Paclitaxel—kidney cancer	0.00718	0.00718	CcSEcCtD
Capreomycin—Hearing impaired—Paclitaxel—kidney cancer	0.00691	0.00691	CcSEcCtD
Capreomycin—Hypokalaemia—Sorafenib—kidney cancer	0.00672	0.00672	CcSEcCtD
Capreomycin—Deafness—Vincristine—kidney cancer	0.00672	0.00672	CcSEcCtD
Capreomycin—Hypokalaemia—Sunitinib—kidney cancer	0.00646	0.00646	CcSEcCtD
Capreomycin—Renal failure—Everolimus—kidney cancer	0.00644	0.00644	CcSEcCtD
Capreomycin—Deafness—Gemcitabine—kidney cancer	0.00637	0.00637	CcSEcCtD
Capreomycin—Urine abnormality—Doxorubicin—kidney cancer	0.00628	0.00628	CcSEcCtD
Capreomycin—Renal failure—Erlotinib—kidney cancer	0.00622	0.00622	CcSEcCtD
Capreomycin—Leukopenia—Temsirolimus—kidney cancer	0.00616	0.00616	CcSEcCtD
Capreomycin—Renal impairment—Gemcitabine—kidney cancer	0.00599	0.00599	CcSEcCtD
Capreomycin—Urine analysis abnormal—Doxorubicin—kidney cancer	0.00591	0.00591	CcSEcCtD
Capreomycin—Hypocalcaemia—Capecitabine—kidney cancer	0.00589	0.00589	CcSEcCtD
Capreomycin—Leukopenia—Pazopanib—kidney cancer	0.00581	0.00581	CcSEcCtD
Capreomycin—Hearing impaired—Capecitabine—kidney cancer	0.00567	0.00567	CcSEcCtD
Capreomycin—Renal failure—Sorafenib—kidney cancer	0.00559	0.00559	CcSEcCtD
Capreomycin—Thrombocytopenia—Temsirolimus—kidney cancer	0.0055	0.0055	CcSEcCtD
Capreomycin—Hypomagnesaemia—Doxorubicin—kidney cancer	0.00547	0.00547	CcSEcCtD
Capreomycin—Renal failure—Sunitinib—kidney cancer	0.00538	0.00538	CcSEcCtD
Capreomycin—Deafness—Paclitaxel—kidney cancer	0.00533	0.00533	CcSEcCtD
Capreomycin—Hypokalaemia—Gemcitabine—kidney cancer	0.00519	0.00519	CcSEcCtD
Capreomycin—Thrombocytopenia—Pazopanib—kidney cancer	0.00518	0.00518	CcSEcCtD
Capreomycin—Renal impairment—Paclitaxel—kidney cancer	0.00501	0.00501	CcSEcCtD
Capreomycin—Pain—Temsirolimus—kidney cancer	0.00481	0.00481	CcSEcCtD
Capreomycin—Tinnitus—Sorafenib—kidney cancer	0.00476	0.00476	CcSEcCtD
Capreomycin—Vertigo—Vinblastine—kidney cancer	0.00462	0.00462	CcSEcCtD
Capreomycin—Leukopenia—Vinblastine—kidney cancer	0.0046	0.0046	CcSEcCtD
Capreomycin—Leukopenia—Everolimus—kidney cancer	0.00458	0.00458	CcSEcCtD
Capreomycin—Pain—Pazopanib—kidney cancer	0.00453	0.00453	CcSEcCtD
Capreomycin—Body temperature increased—Temsirolimus—kidney cancer	0.00444	0.00444	CcSEcCtD
Capreomycin—Abscess—Doxorubicin—kidney cancer	0.0044	0.0044	CcSEcCtD
Capreomycin—Deafness—Capecitabine—kidney cancer	0.00438	0.00438	CcSEcCtD
Capreomycin—Hypokalaemia—Paclitaxel—kidney cancer	0.00434	0.00434	CcSEcCtD
Capreomycin—Renal failure—Gemcitabine—kidney cancer	0.00432	0.00432	CcSEcCtD
Capreomycin—Hypersensitivity—Temsirolimus—kidney cancer	0.00414	0.00414	CcSEcCtD
Capreomycin—Renal impairment—Capecitabine—kidney cancer	0.00411	0.00411	CcSEcCtD
Capreomycin—Thrombocytopenia—Vinblastine—kidney cancer	0.00411	0.00411	CcSEcCtD
Capreomycin—Thrombocytopenia—Everolimus—kidney cancer	0.00409	0.00409	CcSEcCtD
Capreomycin—Leukopenia—Sorafenib—kidney cancer	0.00398	0.00398	CcSEcCtD
Capreomycin—Thrombocytopenia—Erlotinib—kidney cancer	0.00395	0.00395	CcSEcCtD
Capreomycin—Leukopenia—Sunitinib—kidney cancer	0.00383	0.00383	CcSEcCtD
Capreomycin—Hypocalcaemia—Doxorubicin—kidney cancer	0.0038	0.0038	CcSEcCtD
Capreomycin—Oliguria—Doxorubicin—kidney cancer	0.00377	0.00377	CcSEcCtD
Capreomycin—Leukopenia—Dactinomycin—kidney cancer	0.00363	0.00363	CcSEcCtD
Capreomycin—Renal failure—Paclitaxel—kidney cancer	0.00362	0.00362	CcSEcCtD
Capreomycin—Pain—Vinblastine—kidney cancer	0.00359	0.00359	CcSEcCtD
Capreomycin—Pain—Everolimus—kidney cancer	0.00357	0.00357	CcSEcCtD
Capreomycin—Hypokalaemia—Capecitabine—kidney cancer	0.00356	0.00356	CcSEcCtD
Capreomycin—Thrombocytopenia—Sorafenib—kidney cancer	0.00355	0.00355	CcSEcCtD
Capreomycin—Rash—Temsirolimus—kidney cancer	0.00354	0.00354	CcSEcCtD
Capreomycin—Dermatitis—Temsirolimus—kidney cancer	0.00354	0.00354	CcSEcCtD
Capreomycin—Hepatocellular injury—Doxorubicin—kidney cancer	0.00348	0.00348	CcSEcCtD
Capreomycin—Pain—Erlotinib—kidney cancer	0.00345	0.00345	CcSEcCtD
Capreomycin—Thrombocytopenia—Sunitinib—kidney cancer	0.00342	0.00342	CcSEcCtD
Capreomycin—Rash—Pazopanib—kidney cancer	0.00334	0.00334	CcSEcCtD
Capreomycin—Dermatitis—Pazopanib—kidney cancer	0.00333	0.00333	CcSEcCtD
Capreomycin—Body temperature increased—Everolimus—kidney cancer	0.0033	0.0033	CcSEcCtD
Capreomycin—Vertigo—Vincristine—kidney cancer	0.00325	0.00325	CcSEcCtD
Capreomycin—Leukopenia—Vincristine—kidney cancer	0.00324	0.00324	CcSEcCtD
Capreomycin—Thrombocytopenia—Dactinomycin—kidney cancer	0.00324	0.00324	CcSEcCtD
Capreomycin—Body temperature increased—Erlotinib—kidney cancer	0.00319	0.00319	CcSEcCtD
Capreomycin—Pain—Sorafenib—kidney cancer	0.0031	0.0031	CcSEcCtD
Capreomycin—Hypersensitivity—Vinblastine—kidney cancer	0.00309	0.00309	CcSEcCtD
Capreomycin—Hypersensitivity—Everolimus—kidney cancer	0.00308	0.00308	CcSEcCtD
Capreomycin—Tinnitus—Paclitaxel—kidney cancer	0.00308	0.00308	CcSEcCtD
Capreomycin—Leukopenia—Gemcitabine—kidney cancer	0.00307	0.00307	CcSEcCtD
Capreomycin—Pain—Sunitinib—kidney cancer	0.00299	0.00299	CcSEcCtD
Capreomycin—Renal failure—Capecitabine—kidney cancer	0.00297	0.00297	CcSEcCtD
Capreomycin—Thrombocytopenia—Vincristine—kidney cancer	0.00289	0.00289	CcSEcCtD
Capreomycin—Urticaria—Sorafenib—kidney cancer	0.00288	0.00288	CcSEcCtD
Capreomycin—Body temperature increased—Sorafenib—kidney cancer	0.00287	0.00287	CcSEcCtD
Capreomycin—Pain—Dactinomycin—kidney cancer	0.00283	0.00283	CcSEcCtD
Capreomycin—Body temperature increased—Sunitinib—kidney cancer	0.00276	0.00276	CcSEcCtD
Capreomycin—Thrombocytopenia—Gemcitabine—kidney cancer	0.00274	0.00274	CcSEcCtD
Capreomycin—Hypersensitivity—Sorafenib—kidney cancer	0.00267	0.00267	CcSEcCtD
Capreomycin—Renal impairment—Doxorubicin—kidney cancer	0.00265	0.00265	CcSEcCtD
Capreomycin—Rash—Everolimus—kidney cancer	0.00264	0.00264	CcSEcCtD
Capreomycin—Dermatitis—Everolimus—kidney cancer	0.00263	0.00263	CcSEcCtD
Capreomycin—Body temperature increased—Dactinomycin—kidney cancer	0.00261	0.00261	CcSEcCtD
Capreomycin—Vertigo—Paclitaxel—kidney cancer	0.00258	0.00258	CcSEcCtD
Capreomycin—Leukopenia—Paclitaxel—kidney cancer	0.00257	0.00257	CcSEcCtD
Capreomycin—Hypersensitivity—Sunitinib—kidney cancer	0.00257	0.00257	CcSEcCtD
Capreomycin—Rash—Erlotinib—kidney cancer	0.00254	0.00254	CcSEcCtD
Capreomycin—Dermatitis—Erlotinib—kidney cancer	0.00254	0.00254	CcSEcCtD
Capreomycin—Tinnitus—Capecitabine—kidney cancer	0.00253	0.00253	CcSEcCtD
Capreomycin—Pain—Vincristine—kidney cancer	0.00253	0.00253	CcSEcCtD
Capreomycin—Hypersensitivity—Dactinomycin—kidney cancer	0.00244	0.00244	CcSEcCtD
Capreomycin—Pain—Gemcitabine—kidney cancer	0.0024	0.0024	CcSEcCtD
Capreomycin—Body temperature increased—Vincristine—kidney cancer	0.00233	0.00233	CcSEcCtD
Capreomycin—Hypokalaemia—Doxorubicin—kidney cancer	0.0023	0.0023	CcSEcCtD
Capreomycin—Thrombocytopenia—Paclitaxel—kidney cancer	0.0023	0.0023	CcSEcCtD
Capreomycin—Rash—Sorafenib—kidney cancer	0.00229	0.00229	CcSEcCtD
Capreomycin—Dermatitis—Sorafenib—kidney cancer	0.00229	0.00229	CcSEcCtD
Capreomycin—Body temperature increased—Gemcitabine—kidney cancer	0.00221	0.00221	CcSEcCtD
Capreomycin—Rash—Sunitinib—kidney cancer	0.0022	0.0022	CcSEcCtD
Capreomycin—Dermatitis—Sunitinib—kidney cancer	0.0022	0.0022	CcSEcCtD
Capreomycin—Hypersensitivity—Vincristine—kidney cancer	0.00218	0.00218	CcSEcCtD
Capreomycin—Eosinophilia—Doxorubicin—kidney cancer	0.00216	0.00216	CcSEcCtD
Capreomycin—Vertigo—Capecitabine—kidney cancer	0.00212	0.00212	CcSEcCtD
Capreomycin—Leukopenia—Capecitabine—kidney cancer	0.00211	0.00211	CcSEcCtD
Capreomycin—Rash—Dactinomycin—kidney cancer	0.00208	0.00208	CcSEcCtD
Capreomycin—Pain—Paclitaxel—kidney cancer	0.00201	0.00201	CcSEcCtD
Capreomycin—Renal failure—Doxorubicin—kidney cancer	0.00191	0.00191	CcSEcCtD
Capreomycin—Thrombocytopenia—Capecitabine—kidney cancer	0.00188	0.00188	CcSEcCtD
Capreomycin—Urticaria—Paclitaxel—kidney cancer	0.00186	0.00186	CcSEcCtD
Capreomycin—Rash—Vincristine—kidney cancer	0.00186	0.00186	CcSEcCtD
Capreomycin—Dermatitis—Vincristine—kidney cancer	0.00186	0.00186	CcSEcCtD
Capreomycin—Body temperature increased—Paclitaxel—kidney cancer	0.00185	0.00185	CcSEcCtD
Capreomycin—Rash—Gemcitabine—kidney cancer	0.00177	0.00177	CcSEcCtD
Capreomycin—Dermatitis—Gemcitabine—kidney cancer	0.00176	0.00176	CcSEcCtD
Capreomycin—Hypersensitivity—Paclitaxel—kidney cancer	0.00173	0.00173	CcSEcCtD
Capreomycin—Pain—Capecitabine—kidney cancer	0.00165	0.00165	CcSEcCtD
Capreomycin—Tinnitus—Doxorubicin—kidney cancer	0.00163	0.00163	CcSEcCtD
Capreomycin—Urticaria—Capecitabine—kidney cancer	0.00153	0.00153	CcSEcCtD
Capreomycin—Body temperature increased—Capecitabine—kidney cancer	0.00152	0.00152	CcSEcCtD
Capreomycin—Rash—Paclitaxel—kidney cancer	0.00148	0.00148	CcSEcCtD
Capreomycin—Dermatitis—Paclitaxel—kidney cancer	0.00148	0.00148	CcSEcCtD
Capreomycin—Hypersensitivity—Capecitabine—kidney cancer	0.00142	0.00142	CcSEcCtD
Capreomycin—Vertigo—Doxorubicin—kidney cancer	0.00137	0.00137	CcSEcCtD
Capreomycin—Leukopenia—Doxorubicin—kidney cancer	0.00136	0.00136	CcSEcCtD
Capreomycin—Thrombocytopenia—Doxorubicin—kidney cancer	0.00121	0.00121	CcSEcCtD
Capreomycin—Rash—Capecitabine—kidney cancer	0.00121	0.00121	CcSEcCtD
Capreomycin—Dermatitis—Capecitabine—kidney cancer	0.00121	0.00121	CcSEcCtD
Capreomycin—Pain—Doxorubicin—kidney cancer	0.00106	0.00106	CcSEcCtD
Capreomycin—Urticaria—Doxorubicin—kidney cancer	0.000986	0.000986	CcSEcCtD
Capreomycin—Body temperature increased—Doxorubicin—kidney cancer	0.000981	0.000981	CcSEcCtD
Capreomycin—Hypersensitivity—Doxorubicin—kidney cancer	0.000914	0.000914	CcSEcCtD
Capreomycin—Rash—Doxorubicin—kidney cancer	0.000782	0.000782	CcSEcCtD
Capreomycin—Dermatitis—Doxorubicin—kidney cancer	0.000782	0.000782	CcSEcCtD
